Federal Health Agencies 2016 Year in Review
Federal health and science agencies made great strides in 2016 to combat some of the nation’s most pressing health challenges and improve science literacy among the public. Among the achievements, the National Institutes of Health’s (NIH) clinical advances in blood pressure management, age-related macular degeneration, and malaria research. The Centers for Disease Control and Prevention (CDC) worked tirelessly to fight antibiotic resistance, opioid addiction, cancer and other health threats. The National Science Foundation (NSF) supported and highlighted the work of numerous scientists, including one astronomer who stressed the importance of fostering scientific literacy, particularly among young people. Falls by patients resulting in injury were substantially reduced in a hospital setting due to resources from The Agency for Healthcare Research and Quality (AHRQ), and The Food & Drug Administration (FDA) approved novel drug applications at a record-breaking pace. Below is a roundup of 2016 highlights from the NIH, CDC, NSF, AHRQ, and FDA.
- NIH: 2016 Research Highlights — Clinical Breakthroughs
- CDC Year in Review: Working 24/7/365
- NSF Discoveries
- AHRQ Impact Case Studies
- FDA Novel Drug Approvals for 2016
With a new Administration and new Congress soon taking the reins in Washington, D.C., it is imperative that research advocates, scientists, and patient groups increase engagement with policymakers to ensure that medical and health research, science, and innovation is a higher national priority.